🇨🇦 bivalent BNT162b2 (original/Omi BA.4/BA.5) in Canada

bivalent BNT162b2 (original/Omi BA.4/BA.5) (bivalent-bnt162b2-original-omi-ba-4-ba-5) regulatory status in Canada.

Marketing authorisation

bivalent BNT162b2 (original/Omi BA.4/BA.5) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Canada

Frequently asked questions

Is bivalent BNT162b2 (original/Omi BA.4/BA.5) approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for bivalent BNT162b2 (original/Omi BA.4/BA.5) in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.